CTLA4 and neoplasm: Recent data demonstrate that Fc γR-mediated antibody-dependent cellular cytotoxicity (ADCC) is a critical, and perhaps dominant, mechanism underlying anti-CTLA-4 activity in the tumor microenvironment [31,32].